33
https://pubmed.ncbi.nlm.nih.gov/38115336
A patient with gastric neuroendocrine carcinoma achieved good prognosis and survival over 3 years with postoperative chemotherapy, drug resistance treatment, and immunotherapy, suggesting a potential synergistic effect between chemotherapy and immunity.